GLC determination of 17 alpha-ethynylestriol 3-cyclopentyl ether

Area of Science:

• Pharmaceutical Analysis
• Analytical Chemistry
• Drug Development

Background:

• Estrogenic drugs require accurate quantification for therapeutic efficacy and safety.
• Existing analytical methods may lack the sensitivity or speed required for new drug substances.
• 17 alpha-ethynylestriol 3-cyclopentyl ether is a novel estrogenic compound necessitating a robust analytical approach.

Purpose of the Study:

• To develop and validate a rapid, sensitive, and accurate gas-liquid chromatography (GLC) method for the analysis of 17 alpha-ethynylestriol 3-cyclopentyl ether.
• To establish a reliable method for the quantitative determination of this new estrogenic drug in a tablet formulation.

Main Methods:

• Gas-liquid chromatography (GLC) using a column packed with 1% methyl vinyl silicone gum on Gas Chrom Q.
• Derivatization of the drug and internal standard (tetratriacontane) using N-trimethylsilylimidazole.
• Quantification based on computer calculation of peak area ratios of the bistrimethylsilyl derivative.

Main Results:

• A rapid, sensitive, and accurate GLC method was successfully developed for 17 alpha-ethynylestriol 3-cyclopentyl ether.
• The method demonstrated effective separation and quantification of the estrogenic drug.
• The developed GLC method was applied to determine the drug content in a tablet formulation (25 mug/tablet).

Conclusions:

• The developed GLC method provides a reliable and efficient means for the quantitative analysis of 17 alpha-ethynylestriol 3-cyclopentyl ether.
• This analytical method is suitable for quality control and formulation analysis of the new estrogenic drug.
• The study highlights the successful application of GLC in pharmaceutical analysis for novel drug compounds.